Cellyan Biotechnology Co., Ltd (HKPD) Stock Analysis & Investment Frameworks

Cellyan Biotechnology Co., Ltd (HKPD) stock analysis on Invetso. Review Cellyan Biotechnology Co., Ltd’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Cellyan Biotechnology Co., Ltd Company Overview

Cellyan Biotechnology Co., Ltd Key Financial Metrics

About Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.

Cellyan Biotechnology Co., Ltd Investment Frameworks

Invetso analyzes Cellyan Biotechnology Co., Ltd (HKPD) across the following frameworks:

Explore More HKPD Research